Study met both co-primary endpoints and all secondary endpoints At week eight, 67.3% of individuals treated with roflumilast foam achieved Scalp-Investigator Global Assessment (S-IGA) Success compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results